Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
Novartis
Novartis
Autolus Limited
Schrödinger, Inc.
PeproMene Bio, Inc.
Ascentage Pharma Group Inc.
Acepodia Biotech, Inc.
Nkarta, Inc.
Boehringer Ingelheim
Vincerx Pharma, Inc.
Xencor, Inc.
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Eden BioCell Ltd.
Xencor, Inc.
Servier
Servier
ADC Therapeutics S.A.
Sabz Biomedicals
Shenzhen BinDeBio Ltd.
Tianjin Mycure Medical Technology Co., Ltd
Bioceltech Therapeutics, Ltd.
Seagen Inc.
Seagen Inc.
Progen Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Morphotek
Traws Pharma, Inc.
Cellerant Therapeutics
Pharmacyclics LLC.
Novartis
Enzon Pharmaceuticals, Inc.
Daiichi Sankyo
MedImmune LLC